A fridge-free tetanus and diphtheria vaccine has successfully completed phase 1 human trials in the UK, with evidence suggesting it remains effective without refrigeration, even after long-term storage at 30°C for 24 months.
This site is intended for health professionals only
A fridge-free tetanus and diphtheria vaccine has successfully completed phase 1 human trials in the UK, with evidence suggesting it remains effective without refrigeration, even after long-term storage at 30°C for 24 months.
Join our community today and enjoy free, unlimited access to all content. It’s quick, easy, and completely free.
Nursing in Practice delivers a daily dose of incisive news, features, opinions, clinical advice and CPD curated specifically for nurses working in general practice and community settings.
RegisterIf you are not a healthcare professional and would like access to Nursing in Practice content, please contact [email protected].